Home About Us Governance

Governance

Our diverse and accomplished Board possesses the exceptional combination of scientific and technical expertise, leadership acumen, policy knowledge, and innovation strategy skills we need to drive us to achieve our goals. Meet our Board of Directors and Observers.

Board of Directors

Stephen L.
Cummings (Chair)

CPA, CA, FCA(UK), CEPA, CVB
CEO and Managing Partner of Rizolve Partners

Maureen
Adamson

President of Fleming College and Interim President and CEO of Colleges Ontario

Co-Founder of Dig Insights

Jason
Berman

CEO and Scientific Director of the CHEO Research Institute and the Vice President Research at CHEO

Karen
McKay

Vice President Human Resources and Employee Development for Eli Lilly Canada

Pierre
Meulien

PhD
Life Sciences Consultant

Derek
Newton

PhD
Assistant Vice-President, Innovation, Partnerships & Entrepreneurship, University of Toronto

Greg
Pope

CPA, CA, MBA, ICD.D
Managing Partner of GDLP Advisors Inc.

Paula
Rochon

Director of Research at the Weston and O’Born Centre for Mature Women’s Health at Sinai Health

Dominique
Tertigas

PhD Candidate (Surette Lab)
Student Member on the Ontario Genomics Board

Nancy
Tout

PhD, Microbiology and Immunology
Innovation Executive, NLT Innovations

Lyndal
Walker

General Manager of Sun Pharma Canada’s Branded Business

Observers

Rob
Annan

President and CEO, Genome Canada

Colleen
Hogan

Director, Science and Research Branch, Ministry of Colleges, Universities, Research Excellence and Security

Strategic Plan

Ontario Genomics will harness Ontario's world-class biotechnology capabilities to advance better health and a stronger bio-based economy, accelerating the translation of scientific discovery into real-world solutions that deliver impact for patients, customers, and markets across the province and beyond.

View Now

Governance

Board of Directors

Observers

Strategic Plan

Receive Email Updates from Ontario Genomics

What’s Happening in Real-Time